Stock Exchange & Press Releases 2017

Print Print this release
August 24, 2017

Bittium launches new software for analyzing cardiac event-based ECG measurements and long-term Holter measurements at ESC Congress 2017

Press release

Free for publication on August 24, 2017 at 9am (CEST +1)

Bittium launches new software for analyzing cardiac event-based ECG measurements and long-term Holter measurements at ESC Congress 2017

Oulu, Finland, August 24, 2017 - Bittium exhibits its innovative products and solutions for cardiology at ESC Congress 2017 on August 26-30 in Barcelona, Spain. At the event Bittium will launch the new Bittium Cardiac Explorer software for analyzing Cardiac event based ECG recording and Bittium Cardiac Navigator software meant for accurate analyzing of long-term Holter ECG recordings.

The new software, together with the versatile Bittium Faros ECG measuring device, allows the follow-up and detection of cardiac arrhythmias as well as in-depth analysis of long-term recordings. Bittium Cardiac Explorer offers a quick and flexible way of working with event-based ECG arrhythmia analysis. The biggest benefits of the software are having full disclosure ECG always available, full access to the events identified by the device, total control on the reporting content and the ability to analyze an unlimited amount of measurement data. Bittium Cardiac Navigator is a completely new type of solution for the analysis of clinical Holter ECG recordings. Its user-friendly and informative data presentation and intuitive analysis tools make the software easy to use and support its efficient use when analyzing multiple days of ECG recordings. Bittium Cardiac Navigator is designed to speed up the diagnosis and thus allow for longer measurements to be scanned efficiently in a shorter time.

In addition, products and solutions exhibited at the event are:

  • Bittium Faros is a versatile ECG device that is used for early detection of cardiac abnormalities in everyday life. Faros is ultra-small and lightweight, which enables precise long-term full disclosure ECG measurements and recordings, monitoring abnormal cardiac events, mobile cardiac telemetry and assessing autonomic nervous system functioning.

The Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms of Faros device are used for event recording and mobile event monitoring that enable earlier repatriation of patients and even better ability to react to potentially emerging arrhythmias faster. The new, innovative and sophisticated Holter analysis software increases the accuracy and speeds up the analyzing work significantly.

  • Bittium Cardiac Rehabilitation system is a solution for cardiac rehabilitation real-time monitoring for up to 16 patients simultaneously. The system offers safety and efficiency for cardiac rehabilitation by showing each patient’s heart rate, ECG and changes in ST-segment. Utilization of the latest wireless technology allows complete freedom to choose different exercises in various training environments.

More information on the offering: https://www.bittium.com/products__services/medical/bittium_faros

Bittium’s products and solutions are exhibited at stand G330.

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507

Distribution:
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. From November 2016 onwards, Bittium offers its customers also healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2016 was EUR 64.2 million and operating profit was EUR 2.5 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com .